SEC Form 4 · accession 0001179110-15-009336
Tempest Therapeutics, Inc. · TPST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Sexton
Director
Period of report
Jun 4, 2015
Accepted (ET)
Jun 8, 2015 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001544227
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $36.19 | Jun 4, 2015 | A | 20,650 | A | — | Jun 4, 2025 | Common Stock | 20,650 | 20,650 | D |
Explanation of responses
- F1The stock option will vest in twelve equal monthly installments at the end of each successive month following June 4, 2015.